Press Releases for AGN

Press Releases
Spectrum Pharmaceuticals Announces Third Quarter 2009 Corporate Update; ZEVALIN® Sales up 80% over Third Quarter 2008
Phase Forward Reports Third Quarter 2009 Results
Allergan Announces Victory in Brimonidine Patent Infringement Case
Licensing Executives Society Announces 2009 Deals of Distinction Awards
SYSPRO Honored for Business Excellence
BenchmarkJournal.Com Free Analyst Review for ACN, CHL, L, AGN, BA and AMX
Spectrum Pharmaceuticals Announces Second Quarter 2009 Corporate Update
StockPreacher.com issues Trading Outlook for Spectrum Pharmaceuticals Inc.
StreetInvesting.Com Free Research on AGN, DAL, CYH, GNA, JBL and DT
Allergan Reports Second Quarter 2009 Operating Results
ParagonReport.Com Complimentary Earnings Analysis on DRYS, CVX, D and AGN
Allergan Receives FDA Approval for ACUVAIL™ Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery
FDA Designates Fast Track Status for Apaziquone (EOquin®) for Bladder Cancer
Allergan Announces Quarterly Conference Call
Allergan Receives FDA Approval for OZURDEX™ Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease
FDA orders botulinum toxin warnings
Allergan Receives Complete Response Letter for BOTOX® (Botulinum Toxin Type A) for Treatment of Upper Limb Spasticity in Adults
VIDEO: Allergan, Inc. Announces the 'BOTOX(R) Cosmetic: Express Success' Charitable Education Campaign, Committing $250,000 to the Not-For-Profit Dress for Success
Allergan Reports First Quarter 2009 Operating Results
Allergan Comments on Today’s Follow up by the U.S. Food and Drug Administration (FDA) to Its Early Communication, Concluding the Agency’s Safety Review of Botulinum Toxins
Allergan Comments on FDA Requested Class Labeling for Botulinum Toxin Treatments in Connection with Approval of DYSPORT®
Video: Allergan, Inc. Marks 20 Years Since the First Approved Indications by the U.S. Food and Drug Administration for BOTOX(R) (Botulinum Toxin Type A)
Allergan Announces Quarterly Conference Call - Apr 3 2009 4:47PM
Research and Markets: Global Strategic Report Analyzes the Anti-Aging Products in Millions of US$ and Profiles 799 of the Most Prolific Companies in the Industry
Video: Allergan Announces the LATISSE(TM) Wishes Campaign, Committing $1 Million to The Make-A-Wish Foundation(R)
Research and Markets: Medicated Skin Care Products - Global Strategic Business Report
Zacks Analyst Blog Highlights: Ctrip.Com International, ViroPharma, Internap Network Services Corporation, Allergan, Inc. And Comstock Resources.
Allergan Reports Fourth Quarter 2008 Operating Results and Announces Restructuring
Consumer Goods Technology Readers Recognize Paxonix In Readers' Choice Survey For Third Consecutive Year
BenchmarkJournal.Com (Complimentary) Analyst Review for AGN, BSX, GFI and GG
Allergan Announces Quarterly Conference Call - Jan 12 2009 4:51PM
Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
Allergan Announces U.S. Food and Drug Administration (FDA) Approval of LATISSE™ -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
Zacks Bull and Bear of the Day Highlights: AvalonBay, TRW Automotive, Akamai Technologies, Credit Suisse and Allergan
FDA Advisory Committee Unanimously Recommends Approval of LATISSE™ (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes
Spectrum Pharmaceuticals Announces Receipt of $41.5 Million from Allergan, Inc. Per Collaboration Agreement for Apaziquone Announced on October 29th
Technologies, Markets and the Competitive Environment of Drug Delivery Using Nanotechnologies Explored - Oct 31 2008 11:56PM
REMINDER: Minimally Invasive Laparoscopic Gastric Banding Weight Loss Procedure
Technologies, Markets and the Competitive Environment of Drug Delivery Using Nanotechnologies Explored - Oct 31 2008 6:56AM
Allergan Reports Third Quarter 2008 Operating Results
Allergan, Inc. and Spectrum Pharmaceuticals, Inc. Announce Collaboration Agreement for Apaziquone (EOquin(R))
Minimally Invasive Laparoscopic Gastric Banding Weight Loss Procedure
Allergan, Inc. And Clinique Announce Nationwide Availability of CLINIQUE MEDICAL - Oct 16 2008 12:00AM
Allergan, Inc. and Clinique Announce Nationwide Availability of CLINIQUE MEDICAL - Oct 15 2008 9:25AM
Leerink Swann Partners with American Society of Plastic Surgeons to Co-Host Investor Roundtable at 2008 Annual Meeting
Allergan Announces Quarterly Conference Call - Oct 3 2008 5:21PM
Zacks Analyst Blog Highlights: Burger King Holdings, Inc., McDonald's Corp., Allergan, Inc., AutoZone, Inc. And Hudson City Bancorp. - Sep 25 2008 2:19PM
REMINDER: ORLive Presents: Lap-Band(R) Surgery
Allergan Announces Positive Top-Line Results from Phase III BOTOX(R) Headache Program
ORLive Presents: Lap-Band(R) Surgery
Allergan Reports Second Quarter 2008 Operating Results
AEGON Releases EUR 315 Million of Capital Through Securitization
Validity of Allergan Patents Acknowledged by Jan Marini in Settlement of Allergan's Patent Infringement Suit Against Jan Marini Skin Research, Inc.
Legendary Sports Icons, Nadia Comaneci and Mark Spitz, Support Your Personal Best Public Education Campaign
Allergan Completes Acquisition of Aczone Gel 5%
Mark & Associates, P.C. & McGinnis, Lochridge, Kilgore, L.L.P. File Lawsuit Against Botox Maker Over Patient Deaths, Injuries
AEGON Finalizes Acquisition of Turkish Life Insurance and Pension Company
Allergan Announces Quarterly Conference Call - Jul 8 2008 4:52PM
AEGON and Right To Play Announce Global Partnership
AEGON Kicks-Off Lead Sponsorship With Renowned Dutch Soccer Club Ajax
AEGON Strengthens Position in Hungary With Pension Fund Merger
Allergan Receives U.S. Food and Drug Administration Approval for TRIVARIS(TM) (triamcinolone acetonide injectable suspension) 80 mg/mL
Seven Summits Research Releases Alerts on RIMM, V, AMAT, URBN, and AGN
Allergan Announces Agreement to Acquire Aczone(R) Gel 5%
Allergan Announces Intent to File New Drug Application for Bimatoprost as Novel Treatment to Stimulate Natural Eyelash Growth
TEST - Jay 13 - Agnico-Eagle's gold reserves and resources at record levels; gold zones extended at Pinos Altos in Mexico and Kittila in Finland
AEGON Announces Ambitious Targets as Part of new Growth Strategy
REMINDER: ORLive Presents: Experts Discuss Lap Band(R) and Laparoscopic Roux-en-Y Bariatric Procedures
ORLive Presents: Experts Discuss Lap Band(R) and Laparoscopic Roux-en-Y Bariatric Procedures - May 26 2008 10:29PM
Stock Fraction Final Dividend 2007 AEGON N.V. Determined at 1/33 - Jun 1 2008 6:31AM
THE Aesthetic Show Advances $34 Billion Market - Jun 1 2008 6:49AM
AEGON Receives Approval for Pension Fund Merger in Poland - Jun 1 2008 6:30AM
Allergan Reports First Quarter 2008 Operating Results - Jun 1 2008 6:48AM
AEGON N.V. - CEO Alex Wynaendts Interviewed on Q1 results and Market Outlook
Embedded Value Per Share Increased to EUR 13.44 - up 2% and 10% on Constant Currency - Jun 1 2008 6:30AM
AEGON N.V.: Strong Underlying Performance (Up 9%); Net Income Affected by Market Conditions - Jun 1 2008 6:30AM
Seven Summits Research Releases Comments on JAVA, WFC, CHK, LOW, and AGN - May 27 2008 1:16AM
Allergan Announces Research & Development Technology Review - Jun 1 2008 6:48AM
AEGON-CNOOC Opens Guangdong Branch
AEGON and Industrial Securities Complete Asset Management Joint Venture
AEGON Appoints Marco Keim to Lead Dutch Unit
Allergan Announces Quarterly Conference Call - Jun 1 2008 6:47AM
Seven Summits Research Releases Alerts on JPM, QCOM, AGN, UTX, and ZMH